key: cord-1039630-26qx0iro
authors: Fu, Chang; Zhang, Weifeng; Li, Huiqiang; Bai, Yan; Bae, Kyongtae Ty; Wang, Meiyun; Xu, Junling; Shao, Fengmin
title: FDG PET/CT evaluation of a patient recovering from COVID-19
date: 2020-07-15
journal: Eur J Nucl Med Mol Imaging
DOI: 10.1007/s00259-020-04958-w
sha: a2c5b11c323443362f0a021b8ef6447c3cba6d80
doc_id: 1039630
cord_uid: 26qx0iro

nan

A 48-year-old woman presented with 10-day history of cough and fever (up to 39.1°C). Nasopharyngeal swab specimen was positive for COVID-19 nucleic acid test (RT-PCR). Detailed time course of the clinical data, laboratory tests, and imaging findings of computed tomography (CT) and [ 18 F] fluorodeoxyglucose ([ 18 F] FDG) positron emission tomography (PET/CT) are described in the figure. Chest CT obtained from day 7 to day 15 of the hospitalization showed GGOs (ground glass opacities) with crazypaving pattern to consolidative opacities. Following antiviral (hydroxychloroquine hydrochloride and interferon) and antiinflammatory (budesonide and albumin) treatment for several days, the patient was effectively relieved from clinical symptoms and was negative in two subsequent RT-PCR tests (day 13, day 14). [ 18 F] FDG PET/CT scan (day 16) was performed to evaluate any other active disease process.

It showed multiple FDG-positive consolidative opacities in both lungs (PET, fusion; SUV max ranged 2.7-5.9) and multiple FDG-avid lymph nodes in the left subclavian, mediastinum, and hilum regions (arrows, fusion; SUV max ranged 2.9-6.5) A follow-up chest CT acquired 2-month post-discharge (day 77) revealed few GGOs. RT-PCR was again negative. FDG-positive consolidative opacities in both lungs imply persistent inflammatory burden, while the patient was recovering and negative in RT-PCR. FDG-avid lymph nodes also suggest lingering lymphadenitis [1, 2] . FDG uptake may vary with different stages of virus and disease [3] . FDG PET/CT with its capability of directly mapping the location and activity of inflammation during virus exposure may have a role to play when there is uncertainty of diagnosis, for clinical management and for monitoring the effect of treatment [4] .

This article is part of the Topical Collection on Infection and inflammation * Meiyun Wang mywang@ha.edu.cn

Modeling [18F]-FDG lymphoid tissue kinetics to characterize nonhuman primate immune response to Middle East respiratory syndrome-coronavirus aerosol challenge

Middle East respiratory syndrome coronavirus: what does a radiologist need to know?

)F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases

The potential added value of FDG PET/CT for COVID-19 pneumonia

Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations